Antimicrobial resistance research, funding and incentives – get updates next week in London at SMi event
Conference is taking place in London on 19 - 20 March. To join and be a part of the global force head on to Superbugs & Superdrugs website to book your attendance http://www.superbugssuperdrugs.com/ein
PROGRAMME HIGHLIGHTS:
Analyse the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR
• Jean-Pierre Paccaud, Director of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi) - Day 1, 9:15
• Steve Holden, Medical Adviser, MSD - Day 1, 10:35
Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
• Conrad Lichtenstein, CSO, Nemesis bioscience - Day 1, 12:15
• David Brown, Managing Director and Founder, Alchemy Biomedical Consulting - Day 1, 12:55
• Learn about regulatory pathways for the registration of new antimicrobial agents:
• Mair Powell, Senior clinical assessor, MHRA - Day 2, 9:50
Evaluate the latest incentives and funding solutions to spur drug discovery:
• Mark Albrecht, Health Scientist, HHS/ASPR/BARDA - Day 1, 9:55
• Adrian Towse, Director, Office of Health Economics - Day 2, 10:30
Explore the latest novel alternatives to antibiotics currently in development:
• Cara Cassino, Chief Medical Officer, ContraFect - Day 2, 15:10
• Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS Inc - Day 2, 16:20
• Ian Henderson , Professor of Microbial Biology, University Of Birmingham - Day 2, 17:00
View the programme, speaker line-up, and book to attend at http://www.superbugssuperdrugs.com/ein
Superbugs & Superdrugs Team look forward to welcoming you next week to what is shaping up to be another successful show!
Contact:
+44 (0)20 7827 6000
events@smi-online.co.uk
STAY CONNECTED
LinkedIn – search 'SMi Pharma'
Twitter - @SMIpharm #smibugs
-------------------------------------------------------------------------------------------
Superbugs & Superdrugs Conference | 19 - 20 March 2018 | London, UK
http://www.superbugssuperdrugs.com/ein
-------------------------------------------------------------------------------------------
Luda Durneva
SMi Group
email us here
+44 (0)20 7827 6000
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
